| 发明名称 |
USE OF SANGLIFEHRIN IN HCV |
| 摘要 |
The present invention discloses the use of a macrolide compound such as a sanglifehrin for the treatment and prevention of hepatitis C and related diseases such as liver fibrosis, liver cirrhosis and hepatocellular carcinoma.
|
| 申请公布号 |
KR20080033274(A) |
申请公布日期 |
2008.04.16 |
| 申请号 |
KR20087001271 |
申请日期 |
2008.01.16 |
| 申请人 |
NOVARTIS AG |
发明人 |
LIN KAI;WEIDMANN BEAT;ZIMMERMANN KASPAR |
| 分类号 |
A61K31/5025;A61P31/12;A61P35/00 |
主分类号 |
A61K31/5025 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
